These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. Turkheimer FE; Edison P; Pavese N; Roncaroli F; Anderson AN; Hammers A; Gerhard A; Hinz R; Tai YF; Brooks DJ J Nucl Med; 2007 Jan; 48(1):158-67. PubMed ID: 17204713 [TBL] [Abstract][Full Text] [Related]
4. Global-two-stage filtering of clinical PET parametric maps: application to [(11)C]-(R)-PK11195. Tomasi G; Bertoldo A; Cobelli C; Pavese N; Tai YF; Hammers A; Turkheimer FE Neuroimage; 2011 Apr; 55(3):942-53. PubMed ID: 21195193 [TBL] [Abstract][Full Text] [Related]
5. Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer's disease. Tomasi G; Edison P; Bertoldo A; Roncaroli F; Singh P; Gerhard A; Cobelli C; Brooks DJ; Turkheimer FE J Nucl Med; 2008 Aug; 49(8):1249-56. PubMed ID: 18632810 [TBL] [Abstract][Full Text] [Related]
6. Kinetic Modelling and Test-Retest Reproducibility for the Dopamine D Bertoglio D; Verhaeghe J; Miranda A; Wyffels L; Stroobants S; Dominguez C; Munoz-Sanjuan I; Skinbjerg M; Liu L; Staelens S Mol Imaging Biol; 2021 Apr; 23(2):208-219. PubMed ID: 33179158 [TBL] [Abstract][Full Text] [Related]
7. Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195. Kang Y; Schlyer D; Kaunzner UW; Kuceyeski A; Kothari PJ; Gauthier SA PLoS One; 2018; 13(8):e0201289. PubMed ID: 30091993 [TBL] [Abstract][Full Text] [Related]
8. Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies. Yaqub M; van Berckel BN; Schuitemaker A; Hinz R; Turkheimer FE; Tomasi G; Lammertsma AA; Boellaard R J Cereb Blood Flow Metab; 2012 Aug; 32(8):1600-8. PubMed ID: 22588187 [TBL] [Abstract][Full Text] [Related]
9. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Pavese N; Gerhard A; Tai YF; Ho AK; Turkheimer F; Barker RA; Brooks DJ; Piccini P Neurology; 2006 Jun; 66(11):1638-43. PubMed ID: 16769933 [TBL] [Abstract][Full Text] [Related]
10. Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography study. Schuitemaker A; Kropholler MA; Boellaard R; van der Flier WM; Kloet RW; van der Doef TF; Knol DL; Windhorst AD; Luurtsema G; Barkhof F; Jonker C; Lammertsma AA; Scheltens P; van Berckel BN Neurobiol Aging; 2013 Jan; 34(1):128-36. PubMed ID: 22840559 [TBL] [Abstract][Full Text] [Related]
11. A microPET study of the regional distribution of [11C]-PK11195 binding following temporary focal cerebral ischemia in the rat. Correlation with post mortem mapping of microglia activation. Hughes JL; Jones PS; Beech JS; Wang D; Menon DK; Aigbirhio FI; Fryer TD; Baron JC Neuroimage; 2012 Feb; 59(3):2007-16. PubMed ID: 22056528 [TBL] [Abstract][Full Text] [Related]
12. Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study. Versijpt JJ; Dumont F; Van Laere KJ; Decoo D; Santens P; Audenaert K; Achten E; Slegers G; Dierckx RA; Korf J Eur Neurol; 2003; 50(1):39-47. PubMed ID: 12824711 [TBL] [Abstract][Full Text] [Related]
13. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease. Zhou Y; Resnick SM; Ye W; Fan H; Holt DP; Klunk WE; Mathis CA; Dannals R; Wong DF Neuroimage; 2007 Jun; 36(2):298-312. PubMed ID: 17449282 [TBL] [Abstract][Full Text] [Related]
14. Test-retest reproducibility of quantitative binding measures of [ McGinnity CJ; Riaño Barros DA; Rosso L; Veronese M; Rizzo G; Bertoldo A; Hinz R; Turkheimer FE; Koepp MJ; Hammers A Neuroimage; 2017 May; 152():270-282. PubMed ID: 28292717 [TBL] [Abstract][Full Text] [Related]
15. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology. Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290 [TBL] [Abstract][Full Text] [Related]
16. Microglial activation in presymptomatic Huntington's disease gene carriers. Tai YF; Pavese N; Gerhard A; Tabrizi SJ; Barker RA; Brooks DJ; Piccini P Brain; 2007 Jul; 130(Pt 7):1759-66. PubMed ID: 17400599 [TBL] [Abstract][Full Text] [Related]
17. Quantitative longitudinal imaging of activated microglia as a marker of inflammation in the pilocarpine rat model of epilepsy using [ Yankam Njiwa J; Costes N; Bouillot C; Bouvard S; Fieux S; Becker G; Levigoureux E; Kocevar G; Stamile C; Langlois JB; Bolbos R; Bonnet C; Bezin L; Zimmer L; Hammers A J Cereb Blood Flow Metab; 2017 Apr; 37(4):1251-1263. PubMed ID: 27381824 [TBL] [Abstract][Full Text] [Related]